Perbedaan UBC Medical Indonesia Tbk. dan Penta Valent Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Penta Valent Tbk. diperdagangkan di Rp310 (kapitalisasi pasar 547,34 M, volume 24 jam 520,2 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. dan Penta Valent Tbk. berukuran mirip dari sisi kapitalisasi pasar, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,48 jt vs 520,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | PEVE | |
|---|---|---|
Kapitalisasi Pasar | 576,7 M | 547,34 M |
Volume | 3,48 jt | 520,2 rb |
Lot | 34,82 rb | 5,2 rb |
Perputaran | 522,79 jt | 161,08 jt |
Harga Rata-rata | 150,13 | 309,65 |
Nilai Transaksi | 522,79 jt | 161,08 jt |
Harga Ekuilibrium Indikatif | 148 | — |
Volume Ekuilibrium Indikatif | 350 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Penta Valent Tbk (the Company) was established in 1968 in Jakarta, Indonesia under the name of CV Penta Valent, hereinafter, based on Notarial Deed No. 48 of Bebasa Daeng Lalo, S.H., dated August 16, 1972. The Company started its commercial operations in 1968. PT Tancorp Global Sentosa, a company incorporated in Indonesia, is the ultimate parent entity of the Company.
Selengkapnya di halaman PEVE →